检索范围:
排序: 展示方式:
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Wei Zhang, Bixiang Zhang, Xiao-ping Chen
《医学前沿(英文)》 2021年 第15卷 第2期 页码 155-169 doi: 10.1007/s11684-021-0848-3
关键词: hepatocellular carcinoma adjuvant treatment hepatic resection recurrence
Li Jiang, Deng Ning, Xiaoping Chen
《医学前沿(英文)》 2020年 第14卷 第3期 页码 251-261 doi: 10.1007/s11684-019-0727-3
关键词: pancreatic fistula pancreatic body and tail resection distal pancreatectomy
《化学科学与工程前沿(英文)》 2022年 第16卷 第4期 页码 536-545 doi: 10.1007/s11705-021-2067-5
关键词: BCNU glioblastoma recurrence tumor resection nanoparticles hydrogel
Metformin and metabolic diseases: a focus on hepatic aspects
null
《医学前沿(英文)》 2015年 第9卷 第2期 页码 173-186 doi: 10.1007/s11684-015-0384-0
Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of type 2 diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses hepatic glucose production (HGP), serving as the main mechanism by which metformin improves hyperglycemia of T2D. Biochemically, metformin suppresses gluconeogenesis and stimulates glycolysis. Metformin also inhibits glycogenolysis, which is a pathway that critically contributes to elevated HGP. While generating beneficial effects on hyperglycemia, metformin also improves insulin resistance and corrects dyslipidemia in patients with T2D. These beneficial effects of metformin implicate a role for metformin in managing non-alcoholic fatty liver disease. As supported by the results from both human and animal studies, metformin improves hepatic steatosis and suppresses liver inflammation. Mechanistically, the beneficial effects of metformin on hepatic aspects are mediated through both adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. In addition, metformin is generally safe and may also benefit patients with other chronic liver diseases.
关键词: metformin diabetes hepatic steatosis inflammatory response insulin resistance
Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a
null
《医学前沿(英文)》 2017年 第11卷 第2期 页码 191-202 doi: 10.1007/s11684-017-0512-0
Primary hepatic carcinoma (PHC) is a common malignant tumor in China. Cancer is comprehensively treated with various therapeutic regimes, including traditional Chinese medicine (TCM). TCM has been widely used to improve the quality of life, delay the time of cancer progression, and prolong the median survival time. This systematic review with meta-analysis aimed to assess the effect of TCM combined with Western therapy on primary hepatic carcinoma. A comprehensive literature search was conducted in six databases, including CNKI, VIP, Wan-Fang Database, CBM, PubMed, and Cochrane library. A total of 44 randomized controlled trials (RCTs) involving 3429 participants suffering from PHC were selected. Meta-analysis results indicated that the overall effect of TCM and Western integrative treatment on PHC was higher than that of Western intervention alone, which can postpone tumor recurrence and metastasis and prolong the overall survival time of patients with PHC. Although the obtained evidence remained weak because of the poor methodological quality of the included studies, this review provided relevant data supporting the efficacy and safety of TCM combined with Western therapies. In future research, individual RCT studies should incorporate accepted standards for trial design and reporting, proper outcome indicators according to international standards, blinding in allocation concealment, and valid follow-up periods.
关键词: traditional Chinese medicine primary hepatic carcinoma meta-analysis
Ruoxi Zhang, Jing Chen, Diangang Liu, Yu Wang
《医学前沿(英文)》 2019年 第13卷 第3期 页码 398-408 doi: 10.1007/s11684-019-0689-5
关键词: portal hypertension cirrhosis urotensin II palosuran hepatic stellate cell
Beneficial effects of preventive cholecystectomy in patients with hepatic cancer
LIU Anzhong, LI Jun, HUA Huwei
《医学前沿(英文)》 2008年 第2卷 第2期 页码 139-142 doi: 10.1007/s11684-008-0026-x
Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors
null
《医学前沿(英文)》 2012年 第6卷 第3期 页码 317-321 doi: 10.1007/s11684-012-0203-9
In order to find out the potential indicators predicting prognosis of malignant gastrointestinal stromal tumors (GISTs) after surgical resection, we collected clinical records of 80 patients with malignant GISTs. Tumor location, size, mitotic index, necrosis were compared with the prognosis of malignant GISTs by Kaplan-Meier method and log-rank test. After a median follow-up of 844 days (52–2 145), we found that as National Institutes of Health suggested, tumors with intermediate risk had more favorable prognosis than that with high risk. Their 3-year survival rate were 65.3% and 41.3%, respectively (P<0.001). Moreover, tumor size and mitotic index were associated with free survival. The 3-year survival rate for patients with tumor size≤10 cm and>10 cm were 62.3% and 41.8%, respectively (P = 0.002), Tumors with mitotic index≤5/50 HPF had a higher 3-year survival rate than tumors with mitotic index>5/50 HPF (67.1% versus 40.7%, P = 0.005). The presence of necrosis was directly related to the malignant behavior. The 3-year survival rate for presence and absence necrosis were 50.8% and 64.8% (P = 0.008). From the present study, we can conclude that besides tumors size and mitotic index, tumor location and necrosis also influence on the long-term survival of patient with malignant GISTs after surgical resection.
Paeoniflorin prevents hepatic fibrosis of by inhibiting TGF-β1 production from macrophages in mice
CHU Deyong, LI Conglei, SHEN Jilong, WU Qiang
《医学前沿(英文)》 2008年 第2卷 第2期 页码 154-165 doi: 10.1007/s11684-008-0029-7
Endoscopic resection of a huge Brunner's gland adenoma
ZHANG Binbin, REN Xu, TANG Xiufen, CHI Yuxin, SHI Xuesong
《医学前沿(英文)》 2008年 第2卷 第4期 页码 414-418 doi: 10.1007/s11684-008-0080-4
关键词: superior Histological examination endoscopy gastro-intestinal gastrointestinal haemorrhage
Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate
Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU
《医学前沿(英文)》 2009年 第3卷 第1期 页码 36-40 doi: 10.1007/s11684-009-0020-y
关键词: liver cirrhosis beta-elemene hepatic stellate cells angiotensin II receptor angiotensin type 1
Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver
XU Jun, HU Yong, WANG Jian, ZHANG Taiping, ZHOU Ji, YU Hongyu
《医学前沿(英文)》 2007年 第1卷 第3期 页码 264-268 doi: 10.1007/s11684-007-0050-2
关键词: origin Little mesenchymal tissue cords/mesenchymal tissue CD34
Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B
null
《医学前沿(英文)》 2015年 第9卷 第1期 页码 90-99 doi: 10.1007/s11684-015-0390-2
Gene therapy provides a potential cure for hemophilia B, and significant progress has been achieved in liver-directed gene transfer mediated by adeno-associated viral vectors. Recent clinical trials involving the use of a self-complementary adeno-associated virus serotype 8-human codon-optimized factor IX (AAV8-hFIXco) vector demonstrated encouraging efficacy with hFIX expression stabilized at 1% to 6% of normal level in patients, but safety concerns related to high vector doses are still present. Thus, further improvement of AAV vectors and hFIX expression cassette may positively contribute to the ultimate success of hemophilia B gene therapy. In this study, to obtain a higher expression level of hFIX that potentiates the coagulant capacity of recipients, human FIX expression vector was optimized by upgrading the codon adaption index and adjusting the GC content, inserting a Kozak sequence (GCCACC), and introducing a gain-of-function mutation, R338L (FIX Padua). The efficiency of the published and the presently constructed cassettes was compared through in vivo screening. In addition, the regulatory elements that control the FIX gene expression in these cassettes were screened for liver-specific effectiveness. Among all the constructed cassettes, scAAV-Pre-hFIXco-SIH-R338L, which was the construct under the control of the prothrombin enhancer and prealbumin promoter, resulted in the highest level of coagulant activity, and the expression levels of two constructed cassettes (scAAV-Chi-hFIXco-SIH-R338L and scAAV-Pre-hFIXco-SIH-R338L) were also higher than that of the published cassette (scAAV-LP1-hFIXco-SJ). In summary, our strategies led to a substantial increase in hFIX expression at the protein level or a remarkably elevated coagulant activity. Thus, these reconstructs of hFIX with AAV vector may potentially contribute to the creation of an efficacious gene therapy of hemophilia B.
关键词: factor IX hemophilia B liver-specific regulatory elements hydrodynamic gene transfer
Expression of integrin in hepatic fibrosis and intervention of resveratrol
Jianye WU, Chuanyong GUO, Jun LIU, Xuanfu XUAN
《医学前沿(英文)》 2009年 第3卷 第1期 页码 100-107 doi: 10.1007/s11684-009-0013-x
关键词: liver fibrosis integrin-β1 resveratrol tumor growth factor-β tissue inhibitor of metalloproteinase-1
Zhi-Yong ZHANG, Xiao-Ping CHEN, Qi-Ping LU
《医学前沿(英文)》 2010年 第4卷 第3期 页码 317-322 doi: 10.1007/s11684-010-0035-4
关键词: hepatic ischemia-reperfusion digestive tract congestion cholecystokinin vasoactive intestinal peptide salvia miltiorrhiza
标题 作者 时间 类型 操作
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma
Wei Zhang, Bixiang Zhang, Xiao-ping Chen
期刊论文
Prevention and treatment of pancreatic fistula after pancreatic body and tail resection: current status
Li Jiang, Deng Ning, Xiaoping Chen
期刊论文
loaded natural extracellular matrix hydrogel for inhibition of glioblastoma recurrence after tumor resection
期刊论文
Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a
null
期刊论文
Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent
Ruoxi Zhang, Jing Chen, Diangang Liu, Yu Wang
期刊论文
Beneficial effects of preventive cholecystectomy in patients with hepatic cancer
LIU Anzhong, LI Jun, HUA Huwei
期刊论文
Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors
null
期刊论文
Paeoniflorin prevents hepatic fibrosis of by inhibiting TGF-β1 production from macrophages in mice
CHU Deyong, LI Conglei, SHEN Jilong, WU Qiang
期刊论文
Endoscopic resection of a huge Brunner's gland adenoma
ZHANG Binbin, REN Xu, TANG Xiufen, CHI Yuxin, SHI Xuesong
期刊论文
Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate
Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU
期刊论文
Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver
XU Jun, HU Yong, WANG Jian, ZHANG Taiping, ZHOU Ji, YU Hongyu
期刊论文
Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B
null
期刊论文
Expression of integrin in hepatic fibrosis and intervention of resveratrol
Jianye WU, Chuanyong GUO, Jun LIU, Xuanfu XUAN
期刊论文